Enhanced susceptibility to kainate-induced seizures, neuronal apoptosis, and death in mice lacking gangliotetraose gangliosides: protection with LIGA 20, a membrane-permeant analog of GM1.
Knock-out (KO) mice lacking gangliotetraose gangliosides attributable to disruption of the gene for GM2/GD2 synthase [GalNAcT (UDP-N-acetylgalactosamine:GM3/GD3 beta-1,4-N-acetylgalactosaminyltransferase; EC 2.4.1.92 [EC])] are revealing key neural functions for the complex gangliosides of brain. This study has found such animals to be highly susceptible to kainic acid (KA)-induced seizures in terms of both seizure severity and duration. Intraperitoneal injection of 25 mg/kg KA produced status epilepticus for approximately 200 min in normal mice or heterozygotes and more than four times longer in the KO mice. The latter group suffered approximately 30% mortality, which increased to approximately 75% at dosage of 30 mg/kg KA, compared with 10-14% for the other two genotypes at the latter dosage. Nissl staining and terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick end labeling assay revealed substantial deterioration of pyramidal neurons attributable to apoptosis in the KO hippocampus, especially the CA3 region. Seizure activity in the KO mouse was only moderately diminished by intraperitoneal injection of GM1 ganglioside, whereas LIGA 20, a semisynthetic analog of GM1, substantially reduced both seizure severity and cell damage. The potency of LIGA 20 was correlated with its enhanced membrane permeability (compared with GM1), as seen in the increased uptake of [3H]LIGA 20 into the subcellular fractions of brain including cell nuclei. The latter finding is consonant with LIGA 20-induced restoration of the Na+/Ca2+ exchanger located at the inner membrane of the nuclear envelope in KO mice, an exchanger dependent on tight association with GM1 or its analog for optimal activity. These results point to a neuroprotective role for GM1 and its associated exchanger in the nucleus, based on regulation of Ca2+ flux between nucleoplasm and nuclear envelope.
Wu
Gusheng
G
Department of Neurology and Neurosciences, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey 07103, USA.
Lu
Zi-Hua
ZH
Wang
Jianfeng
J
Wang
Yvette
Y
Xie
Xin
X
Meyenhofer
Markus F
MF
Ledeen
Robert W
RW
D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D001921:Brain / Q000378:metabolism; D004198:Disease Susceptibility; D005677:G(M1) Ganglioside / Q000031:analogs & derivatives* / Q000172:deficiency / Q000493:pharmacokinetics / Q000494:pharmacology; D005732:Gangliosides / Q000172:deficiency / Q000378:metabolism*; D006624:Hippocampus / Q000503:physiopathology; D007608:Kainic Acid; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D017350:N-Acetylgalactosaminyltransferases / Q000172:deficiency; D009474:Neurons; D018696:Neuroprotective Agents / Q000494:pharmacology*; D009844:Oligosaccharides / Q000172:deficiency; D012640:Seizures / Q000139:chemically induced / Q000401:mortality* / Q000503:physiopathology*; D019831:Sodium-Calcium Exchanger / Q000187:drug effects / Q000378:metabolism; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology; D013226:Status Epilepticus / Q000139:chemically induced / Q000503:physiopathology; D013997:Time Factors
D005732:Gangliosides; D018696:Neuroprotective Agents; D009844:Oligosaccharides; D019831:Sodium-Calcium Exchanger; C086919:LIGA 20; D005677:G(M1) Ganglioside; C099478:gangliotetraose; D017350:N-Acetylgalactosaminyltransferases; C023220:(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase; D013110:Sphingosine; D007608:Kainic Acid